(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LUMICAIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LUMICAIN

ST13

US500000076061179

Class

5

Filing

76061179

Registration

2463881

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

10/16/2020

Trademark type

Word

Nice classes

5

Filing date

06/05/2000

Registration date

06/26/2001

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/16/2020

Last transaction

10/16/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

10/16/1972

First use in commerce

10/16/1972

Drawing code

1

Owner type

03

Owner location

Philadelphia, PA

Examiner

SNAPP, TINA

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MEDICAL PRODUCTS LABORATORIES , INC.

Representatives

Stanley H. Cohen Caesar Rivise, PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

topical hemostatic preparation for control of minor hemorrhaging

Publications

History of USPTO decisions and trademark events.

21 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/16/2020

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/16/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/16/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/16/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

08/28/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/26/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/16/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/16/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

08/13/2010

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/05/2007

PLGL

ASSIGNED TO PARALEGAL

01/08/2007

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

11/03/2006

E815

TEAS SECTION 8 & 15 RECEIVED

11/03/2006

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/12/2006

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/12/2006

CFIT

CASE FILE IN TICRS

10/12/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

06/26/2001

PUBO

PUBLISHED FOR OPPOSITION

04/03/2001

NPUB

NOTICE OF PUBLICATION

03/21/2001

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/07/2000

DOCK

ASSIGNED TO EXAMINER

10/26/2000

Continuous trademark protection

Get notified about every new filing that threatens LUMICAIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.